- World rank, all time
- #38,811 of 42,892
- Rank in Canada
- #840 of 896
- Research works
- 128 ▼ 13% vs 2013–17
- Citations
- 2.2k 17.0 per fractional work
- Top-10% rate
- 6.9% record average 16.5%
- Open access
- 35% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 4.2×. Every wedge is a field page.
- Nursing 4.2×
- Medicine 3.4×
- Pharmacology, Toxicology and Pharmaceutics 2.9×
- Immunology and Microbiology 2.5×
- Energy 2.2×
- Biochemistry, Genetics and Molecular Biology 1.9×
- Economics, Econometrics and Finance 1.6×
- Health Professions 1.1×
- Business, Management and Accounting 0.7×
- Computer Science 0.5×
- Social Sciences 0.3×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.0×
Which keywords describe research at Leukemia & Lymphoma Society of Canada?
By fractional works in all years, weighted toward what it does more of than the world: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Rituximab, Lymphoma, Mesenchymal Stem Cells and BCR-ABL.
- Cancer Immunotherapy
- European Union
- Acute Lymphoblastic Leukemia
- Leukemia
- International Myeloma Working Group
- Proteasome Inhibitors
- Prognostic Scoring System
- International Law
- Immunotherapy
- Genomic Aberrations
- Classification
- Corrective Justice
- Contract Law
- Cancer
- Graft-versus-Host Disease
- Mesenchymal Stem Cells
- BCR-ABL
- Lymphoma
- Acute Myeloid Leukemia
- Hematopoietic Stem Cells
- Prognostic Factors
- AML
- Rituximab
- Human Rights
- Imatinib
- Bone Marrow Niche
- Property Rights
- Chemotherapy
- Minimal Residual Disease
- Remedies
- Chronic Lymphocytic Leukemia
- PET Imaging
- Genetic Pathogenesis
- Molecular Profiling
- Staging System
- Diagnosis Criteria
- JAK2 Mutation
- Myelofibrosis
- Childhood Cancer
- Immigration
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Prognostic Factors18▲ 31×6 topics
- Hematopoietic Stem Cells17▲ 129×3 topics
- AML11▲ 178×1 topic
- Acute Myeloid Leukemia11▲ 178×1 topic
- Rituximab8▲ 38×3 topics
- Lymphoma6▲ 31×3 topics
- Human Rights6▲ 5.4×12 topics
- BCR-ABL6▲ 161×1 topic
- Imatinib6▲ 161×1 topic
- Mesenchymal Stem Cells6▲ 38×3 topics
- Bone Marrow Niche6▲ 129×1 topic
- Graft-versus-Host Disease6▲ 129×1 topic
- Property Rights5▲ 37×3 topics
- Cancer5▲ 2.7×13 topics
- Chemotherapy5▲ 5.5×12 topics
- Contract Law5▲ 95×2 topics
- Minimal Residual Disease5▲ 58×2 topics
- Corrective Justice5▲ 146×1 topic
- Remedies5▲ 146×1 topic
- Classification4▲ 9.3×2 topics
- Chronic Lymphocytic Leukemia4▲ 66×1 topic
- Genomic Aberrations4▲ 66×1 topic
- PET Imaging4▲ 14×4 topics
- Immunotherapy4▲ 4.7×8 topics
- Genetic Pathogenesis4▲ 47×1 topic
- International Law4▲ 10×6 topics
- Molecular Profiling4▲ 24×1 topic
- Prognostic Scoring System3▲ 70×2 topics
- Staging System3▲ 35×2 topics
- Proteasome Inhibitors3▲ 30×2 topics
- Diagnosis Criteria3▲ 68×1 topic
- International Myeloma Working Group3▲ 68×1 topic
- JAK2 Mutation2▲ 92×1 topic
- Leukemia2▲ 28×2 topics
- Myelofibrosis2▲ 92×1 topic
- Acute Lymphoblastic Leukemia2▲ 49×1 topic
- Childhood Cancer2▲ 49×1 topic
- European Union2▲ 6.9×2 topics
- Immigration2▲ 14×2 topics
- Cancer Immunotherapy2▲ 12×2 topics
Which research topics does Leukemia & Lymphoma Society of Canada publish most on?
By volume in 2022–2025: Acute Myeloid Leukemia Research, Global Cancer Incidence and Screening, Hematopoietic Stem Cell Transplantation and Chronic Myeloid Leukemia Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Acute Myeloid Leukemia Research Hematology 1 works
- 2 Global Cancer Incidence and Screening Oncology 1 works
- 3 Hematopoietic Stem Cell Transplantation Hematology 1 works
- 4 Chronic Myeloid Leukemia Treatments Hematology 1 works
- 5 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 6 Neutropenia and Cancer Infections Oncology 0 works
- 7 CAR-T cell therapy research Oncology 0 works
- 8 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
- 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 10 Dermatologic Treatments and Research Dermatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Leukemia & Lymphoma Society of Canada's research output changed?
Output in 2018–2022 was 13% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Toronto
- University of Toronto
- York University
- Hospital for Sick Children
- Toronto Metropolitan University
- University Health Network
- Sunnybrook Health Science Centre
- St. Michael's Hospital
- Princess Margaret Cancer Centre
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.